Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obeticholic acid in bile acid diarrhoea
2011-003777-28Phase 2Completed
- Sponsor
- Imperial College London and Imperial College Healthcare NHS Trust
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of obeticholic acid in Bile acid diarrhea (BAD) (3 arms), sponsored by Imperial College London and Imperial College Healthcare NHS Trust. Primary endpoint: Change in fasting serum fibroblast growth factor 19. Started Mar 2012; status: completed.
02
Drugs
obeticholic acid
03
Conditions
Bile acid diarrhea (BAD)
Beyond the preview
Go deeper on 2011-003777-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003777-28.